To investigate the expression of ICAM-1 as a carcinogenesis mediator in the patients with PTC and those with HT, the expression of ICAM-1 mRNA was detected in the thyroid cancer tissues of each group by RT-PCR. The gene discussed is ICAM1; the disease is hematocrit.